NCT06955442

Brief Summary

Ischemic stroke is one of the leading causes of mortality and disability worldwide. Although the prevalence of stroke is high globally, not all ethnic and racial groups are affected in the same way, leading to the classification of stroke as an inequitable disease. First of all, ethnic and racial background influences the pathogenesis of stroke, as numerous risk factors-both modifiable and non-modifiable-are more prevalent in Black and Hispanic populations compared to Asian ones. As a direct consequence, the incidence of stroke is higher in Black and Hispanic individuals than in White individuals. Unfortunately, despite this, access to revascularization treatments is not always guaranteed for ethnic and racial minorities, although in recent years, this inequality in access to care appears to be decreasing. Moreover, stroke prognosis also seems to differ based on race/ethnicity, with mortality being higher among Black individuals compared to White individuals, although this trend tends to decrease with advancing age. On the other hand, although cerebral hemorrhage is more prevalent in Black and Asian populations than in White populations, it tends to have a better prognosis in these minority groups. It must be considered, however, that the vast majority of studies on this topic have been conducted in the United States, where the ethnic and racial composition of the population is very different from that of Italy and Europe. In these latter contexts, studies investigating the impact of race and/or ethnicity on the clinical characteristics, management, and prognosis of ischemic stroke are lacking. Furthermore, differences in healthcare system organization may play a significant role in limiting access to timely and appropriate medical care for acute stroke based on race and/or ethnicity. Italy is a country where, similarly to other European nations, the last few decades have seen a significant increase in immigration rates, particularly from Eastern Europe. Today, foreigners account for approximately 9% of the total population. Nevertheless, in Italy, systemic racism toward ethnic and racial minorities remains a significant issue, as evidenced by large disparities in educational attainment, socioeconomic status, and housing conditions between Italian citizens and foreign residents. Although the universal national healthcare system in Italy should ensure equal access to care and emergency treatment for all, regardless of ethnic and racial background, there are no studies investigating this topic. A recent scoping review highlighted how individual racism plays a primary role in generating health inequalities, whereas there is very limited evidence focused on the analysis of structural and institutional racism in the Italian and European context. As a consequence, this study aims to prospectively investigate the presence and the extent of racial and ethnic disparities in access to stroke care and treatment across several Italian comprehensive stroke centers.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4,500

participants targeted

Target at P75+ for all trials

Timeline
9mo left

Started Apr 2025

Geographic Reach
1 country

15 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress61%
Apr 2025Jan 2027

Study Start

First participant enrolled

April 3, 2025

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

April 16, 2025

Completed
16 days until next milestone

First Posted

Study publicly available on registry

May 2, 2025

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2027

Last Updated

May 2, 2025

Status Verified

April 1, 2025

Enrollment Period

1.5 years

First QC Date

April 16, 2025

Last Update Submit

April 24, 2025

Conditions

Keywords

StrokeIschemic StrokeHealth disparitiesEquity in healthcare

Outcome Measures

Primary Outcomes (1)

  • Racial/ethnic disparities in the access to revascularization treatments

    Comparison of the likelihood of undergoing revascularization treatments among patients from different racial and/or ethnic groups.

    Baseline

Secondary Outcomes (9)

  • Racial/ethnic disparities in onset to door times

    Baseline

  • Racial/ethnic disparities in door to needle times

    From the time of ED admission at baseline to start of intravenous thrombolysis

  • Racial/ethnic disparities in door to groin times

    From the time of ED admission at baseline to femoral puncture for mechanical thrombectomy

  • Racial/ethnic differences in mode of emergency department arrival

    Baseline

  • Racial/ethnic differences in the prevalence of cardiovascular risk factors

    Baseline

  • +4 more secondary outcomes

Study Arms (1)

Patients presenting to the ED for acute ischemic stroke

Patients will be divided into several subgroups based on their racial/ethnic belonging (Asian/Hispanic/Black/White/Others).

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients presenting to the ED of a hospital for a suspected stroke diagnosis. Patients will be then divided into different subgroups according to their racial/ethnic belonging (White, Asian, Hispanic, Black, Others).

You may qualify if:

  • Adults (≥18 years old);
  • Admission to the Emergency Department of the participating center with a diagnosis of ischemic stroke, as defined by the International Classification of Diseases, 9th Revision (ICD-9) codes;
  • Signed informed consent provided by the patient or, in cases of impaired decision-making capacity, by their legal guardian/representative.

You may not qualify if:

  • Discharge diagnosis other than ischemic stroke;
  • Refusal to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (15)

Ospedale Maggiore, IRCCS Istituto delle Scienze Neurologiche di Bologna - UO Neurologia OM e Rete Stroke Metropolitana (SC)

Bologna, 40124, Italy

Location

UOS Neurologia-AOU, IRCCS Istituto delle scienze Neurologiche

Bologna, 40124, Italy

Location

UOC Neurologia, ASST Crema

Crema, 26013, Italy

Location

UOC Neurologia - Ospedale Spaziani

Frosinone, 03100, Italy

Location

IRCCS Ospedale Policlinico San Martino

Genova, 16132, Italy

Location

Ospedale Vito Fazzi

Lecce, 73100, Italy

Location

Azienda Ospedaliera di Rilievo Nazionale Antonio Cardarelli

Naples, 80131, Italy

Location

Fondazione IRCCS Policlinico San Matteo

Pavia, 27100, Italy

Location

IRCCS Fondazione Istituto Neurologico C. Mondino

Pavia, 27100, Italy

Location

IRCCS Istituto Neurologico Mediterraneo Neuromed

Pozzilli, 86077, Italy

Location

Policlinico Tor Vergata

Roma, 00133, Italy

Location

Policlinico Umberto I

Rome, 00161, Italy

Location

Fondazione Policlinico Universitario A. Gemelli IRCCS

Rome, 00168, Italy

Location

Humanitas Research Hospital IRCCS

Rozzano, 20089, Italy

Location

UOC Neurologia Belcolle - Ospedale Belcolle

Viterbo, 01100, Italy

Location

Related Publications (1)

  • Frisullo G, Scala I, Di Giovanni J, Rizzo PA, Bellavia S, Broccolini A, Monforte M, Franceschi F, Gasbarrini A, Carbone L, Calabresi P, Covino M. Racial and ethnic differences in access to care and treatment in patients with suspected acute stroke: A retrospective, observational, cohort study. J Neurol Sci. 2024 Nov 15;466:123225. doi: 10.1016/j.jns.2024.123225. Epub 2024 Sep 10.

    PMID: 39270410BACKGROUND

MeSH Terms

Conditions

Ischemic StrokeStroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Giovanni Frisullo

    Fondazione Policlinico Universitario A. Gemelli, IRCCS

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 16, 2025

First Posted

May 2, 2025

Study Start

April 3, 2025

Primary Completion (Estimated)

October 15, 2026

Study Completion (Estimated)

January 15, 2027

Last Updated

May 2, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations